Reverse Phase Protein Arrays-Quantitative Assessment of Multiple Biomarkers in Biopsies for Clinical Use.
Reverse Phase Protein Arrays (RPPA) represent a very promising sensitive and precise high-throughput technology for the quantitative measurement of hundreds of signaling proteins in biological and clinical samples. This array format allows quantification of one protein or phosphoprotein in multiple samples under the same experimental conditions at the same time. Moreover, it is suited for signal transduction profiling of small numbers of cultured cells or cells isolated from human biopsies, including formalin fixed and paraffin embedded (FFPE) tissues. Owing to the much easier sample preparation, as compared to mass spectrometry based technologies, and the extraordinary sensitivity for the detection of low-abundance signaling proteins over a large linear range, RPPA have the potential for characterization of deregulated interconnecting protein pathways and networks in limited amounts of sample material in clinical routine settings. Current aspects of RPPA technology, including dilution curves, spotting, controls, signal detection, antibody validation, and calculation of protein levels are addressed.
Institut für Pathologie, Technische Universität München, Trogerstrasse 18, 81675 München, Germany. stefanie.boellner@tum.de.
Stefanie
S
Boellner
Institut für Pathologie, Technische Universität München, Trogerstrasse 18, 81675 München, Germany. kf.becker@lrz.tum.de.
Karl-Friedrich
KF
Becker
FFPE; antibody; cancer; diagnostics; personalized medicine; protein; therapy; tissue